PHARMABOARDROOM





Proficient Pharma Market

Several elements are driving the development of the Swiss pharma market, which grew by 2.8% in 2019. This growth was driven mainly by the volume of medicines sold (+2.9%). New products – e.g. for cancer or autoimmune diseases – have likewise contributed to this growth. There are ever more medicines for hitherto untreatable diseases. The triennial price reviews by the FOPH have led to a 2.7% decline in the overall market. With these savings, the pharmaceutical industry is making a major contribution to help contain the growth of costs in the healthcare system.

Since 2005, the Swiss generics market has almost tripled in value. Reimbursable generics achieved a value of around 735 million francs in 2019. In the generics-eligible market, the proportion of generics has been stable for years. This market includes not only generics themselves, but also off-patent originals from which generics exist. In addition, however, there are also originals of which there are no generic versions because, among other factors, their prices are already so low that they are not economically attractive for generics producers.

GGBA icons+

Around 2/3 of all medicine packs are bought in pharmacies.

GGBA icons

In the case of a medicine priced at 100 francs, 68 goes to the producer and 32 to the trade, to doctors, pharmacists and, through value-added tax, to the federal goverment.

GGBA icons

Since 2012, more than 1 billion francs have been saved through price reviews of medicines. The market volume in 2019 was CHF 6,136.5 million.

Made with Visme Infographic Maker

Made with Visme Infographic Maker

Made with Visme Infographic Maker

Made with Visme Infographic Maker

Made with Visme Infographic Maker

Why do companies invest in Western Switzerland?


Flawless Operations


Skilled & Flexible Talent


Vibrant Life Sciences Environment


Ease of Setting Up a Business


Successful Peer Companies

Quality of Life


The Region


Education

HubsGoGlobal is a platform under the PharmaBoardroom brand that focuses on the competitive advantages of the Hub and its value proposition in terms of strategic, operational, financial, talent and lifestyle aspects.

PharmaBoardroom provides industry trends, news and reports from all over the world. This site is for senior professionals who want to understand local and global markets.

CONTACT



Greater Geneva Bern area is an initiative of the cantons of
Bern, Fribourg, Vaud, Neuchâtel, Geneva and Valais.

World Trade Center – Av. de Gratta-Paille 2
PO Box 252
1000 Lausanne 22 – Switzerland

CONTACT


Copyright: All rights reserved. No part of this site maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this website, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors.

2021 © PharmaBoardroom